Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance-Reference-Cited by-同舟云学术

Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance

Published:2022-04-06 Issue:6 Volume:80 Page:982-994
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Graham Martinez Cristina¹^ORCID,Kus Öztürk Sonay¹,Al‐Kaabi Ali²,Valkema Maria J³,Bokhorst John‐Melle¹,Rosman Camiel⁴,Rütten Heidi⁵,Wauters Carla A P⁶,Doukas Michail⁷,Lanschot Joseph Jan‐Baptist³,Siersema Peter D²,Nagtegaal Iris D¹^ORCID,Post Rachel Sofia¹

Affiliation:

1. Department of Pathology Radboud University Medical Centre Nijmegen the Netherlands

2. Department of Gastroenterology and Hepatology Radboud University Medical Centre Nijmegen the Netherlands

3. Department of Surgery, Erasmus MC Cancer Institute Erasmus University Medical Centre Rotterdam Rotterdam the Netherlands

4. Department of Surgery Radboud University Medical Centre Nijmegen the Netherlands

5. Department of Radiotherapy Radboud University Medical Centre Nijmegen the Netherlands

6. Department of Pathology Canisius Wilhelmina Hospital Nijmegen the Netherlands

7. Department of Pathology, Erasmus MC Cancer Institute Erasmus University Medical Centre Rotterdam Rotterdam the Netherlands

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14644

Reference31 articles.

1. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

2. Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer

3. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

5. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment;Frontiers in Oncology;2023-09-05

2. Relevance of shrinkage versus fragmented response patterns in rectal cancer;Histopathology;2023-08-23

3. Deep learning for multi-class semantic segmentation enables colorectal cancer detection and classification in digital pathology images;Scientific Reports;2023-05-24

4. Rectal tumor fragmentation as a response pattern following chemoradiation;Journal of Gastrointestinal Oncology;2022-12

5. The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy;Journal of Cancer Research and Clinical Oncology;2022-10-06